FDA approves Amplatzer


News announcement from FDA you’ll be interested in if you’ve suffered a cryptogenic stroke from a suspected PFO and need more choice for treatment.


Update to Recent Post: Long Journey to Improve PFO Patient Voice and treatment Options for Cryptogenic Stroke

Wow, I have personally spent lots of time advocating for this important stroke/PFO patient matter over many, many years but hard work has now paid off.  The FDA announced last week the Amplatzer is now finally approved for recurrent cryptogenic stroke treatment in certain PFO patients!

Congrats and recognition for the commitment from the original team of PFO patients (formerly PFO Research Foundation in the US) that I began this important advocacy journey on with together so many years ago. Thank you!

Read the FDA Notice:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm527096.htm

Take look back at my FDA testimony and this PFO journey background here:

http://www.know-stroke.org/a-long-journey-to-improve-pfo-patients-voice-and-treatment-options-for-cryptogenic-stroke/

bostonfinishlinedansereau
What a Journey !
Advertisements

PFO Closure Poll Results Favorable (So Far)


A while back we asked you to take this poll….

Have You Had PFO Closure?  Take Our Quick Poll:


Many patient’s report improvement in symptoms and sometimes even complete resolution of symptoms after PFO closure, while other patients report mixed results.  If this applies to you, I hope you’ll chime in here how you feel after closure in this very unscientific anonymous poll:


 

So now for a quick PFO Closure Poll update, here’s how the polling results are going so far (340 responders to date)…

PFO Closure Poll Results at Know-Stroke.org
PFO Closure Poll Results at Know-Stroke.org

 

Stroke Recovery Goal Setting Action Guide


In my last post I mentioned my book Body in Balance is a great place to find help with how to create an action plan for achieving your own goals.  I forgot to mention I also have a great free stroke recovery goals setting action guide you can access right away with this instant download.  It is part of my home stroke recovery goal setting webinar.  You can still register for the free webinar rebroadcast, download this action guide and get started building smart goals of your own!


largeregisternowlarge

Take Action!


 
thickpaperbackfronttrans200x319Buy Now on Amazon!

 

TCD and PFO Study Results


TCD is Superior to TEE for Detection of PFO (Patent Foramen Ovale)

AHAScience News-International Stroke Conference 2014-San Diego

Ralph Sacco, MD, FAHA, past-president of the American Heart Association, interviews David Spence, MD, primary investigator of the trial, “Transcranial Doppler Is Superior to Transesophageal Echocardiography in Detection of Patent Foramen Ovale,” which he presented at ISC 2014 in San Diego.

TCD and PFO Study Summary:

The researchers conducted a study to compare the performance of transcranial Doppler (TCD) with transesophageal echocardiography (TEE), the standard method for diagnosing a right-left shunt such as PFO. They hypothesized that transcranial Doppler saline studies would be more sensitive, in part because sedation for TEE could prevent an adequate Valsalva maneuver.

Watch the video and see the TCD/PFO study results

Learn More About PFO
Learn More About PFO

St. Jude Medical RESPECT Trial for PFO Closure Provides Clinical Evidence of Risk Reduction in Prevention of Recurrent Cryptogenic Stroke – MarketWatch


“The Street” is certainly on the pulse of PFO as you may already be aware.  They were first to report.  But what does it mean??  Be careful not to just follow St. Jude stock today.  Here’s the early MarketWatch Report:
http://www.marketwatch.com/story/st-jude-medical-respect-trial-for-pfo-closure-provides-clinical-evidence-of-risk-reduction-in-prevention-of-recurrent-cryptogenic-stroke-2012-10-25

 

David Dansereau at Know-Stroke.org

St. Jude Faces Boon-or-Bust Verdict on Heart-Plug Studies – Businessweek


http://mobile.businessweek.com/news/2012-10-24/st-dot-jude-faces-boon-or-bust-verdict-on-heart-plug-studies

What is the most frequent source of cardioembolic stroke in young adults?


This question (and the answer below) appeared in today’s Resident e-Bulletin / Teaching Topics from the New England Journal of Medicine

Patent foramen ovale (PFO) is the most frequent cardioembolic risk factor for stroke in young adults. Others include congenital heart disease, infectious nonbacterial thrombotic endocarditis, rheumatic valvular heart disease, cardiac surgery or catheter intervention, arrhythmia (e.g., atrial fibrillation or sick sinus syndrome), cardiac tumors (e.g., atrial myxoma or papillary fibroelastoma), recent myocardial infarction, and dilated cardiomyopathy.

Up to 14% of all strokes occur in children and young adults. The incidence rates are 10 to 23 ischemic strokes per 100,000 young adults (18 to 50 years of age) and 3 to 9 hemorrhagic strokes per 100,000 young adults. Unfortunately, stroke remains under recognized and often misdiagnosed in young adults, particularly those less than 35 years of age and those with abnormalities in the posterior circulation.

To read more and to review a case study of an 18 year old patient at MGH that NEJM is featuring in their current issue click here

David Dansereau at Know-Stroke.org

 

 

 

 

David Dansereau for Know-Stroke.org